An interventional study of Exercise therapy and Manual Therapy in Back Pain, Neck Pain and Low Back Pain, sponsored by Catholic University of Murcia. Enrolling by invitation at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-21.
Sponsored by Catholic University of Murcia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 168 studies in Low Back Pain with a site in Spain — 20 open to participants now, 22 under way, 1 of them phase 3. Low Back Pain · Spain.
Among the 168 studies in Low Back Pain with a site in Spain, this one is the 71st largest by planned enrollment of the 148 interventional ones that give a count, is one of 4 that started in 2025, is one of 131 with no phase, reaches primary completion later than 18 of the 21 other live ones, and was the 159th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →20 of the 168 studies in Low Back Pain with a site in Spain are open now. Recruiting first, the newest first:
Marc Badia · Sites in Spain
Ages 18+
University of Valencia · Sites in Spain
Ages 18–65
Institut d'Investigacions Biomèdiques August Pi i Sunyer · Sites in Spain
Ages 18–65
European University of Madrid · Sites in Spain
Ages 18–65
University of Seville · Sites in Spain
Ages 18–50
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
168 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 8 · Phase 3 5 · Phase 4 2
First in 2005; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 60 across the 148 interventional studies, 137 across the 20 observational. Of the 121 that completed or were terminated, 9 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 168 have an industry lead sponsor. The 10 most frequent:
Catholic University of Murcia is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Catholic University of Murcia has 1 study filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
5 of the studies in Low Back Pain with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06446596University of ValenciaTelerehabilitation-based Exercises vs Standard Home-based Exercise in Low Back Pain | 2026-12 |
| NCT07467408Consorci Sanitari de TerrassaTreatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU) | 2026-12-31 |
| NCT06527339Universidad de ZaragozaEffect of Dry Needling Plus Vibration on Myofascial Trigger Points in Individuals With Nonspecific Low Back Pain | 2027-01 |
| NCT06873386Marc BadiaUltrasound-guided Percutaneous Electrical Stimulation for Gluteus Muscle Dysfunction After Low Back Pain Episode | 2027-02-15 |
| NCT07251959Catholic University of MurciaWorkplace Exercise Therapy With or Without Manual Therapy in Chronic Spinal Pain | 2027-06 |
Add all 5 to your calendar (.ics) → With an account.
Among the 168 studies in Low Back Pain with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Implementing workplace strategies to manage symptoms in office workers with chronic nonspecific spinal pain (CNSP) may improve both health- and work-related outcomes, as adherence to these interventions is more feasible in this context. Exercise therapy is considered the first-line treatment for CNSP; however, the added value of combining exercise therapy with manual therapy remains inconclusive. This study aims to examine the effects of short sessions of exercise therapy plus manual therapy, compared with exercise therapy plus sham manual therapy, delivered in the workplace, on health- and work-related outcomes in office workers with CNSP.
Objectives: To evaluate the effects of short sessions of exercise therapy plus manual therapy compared with exercise therapy plus sham manual therapy at work on self-perceived productivity, disability, global impression of change, pain intensity, depression, anxiety, and muscle tone.
Methods: A randomized controlled trial will be conducted. The study protocol was approved by the Research Ethics Committee of Catholic University of Murcia (UCAM) (CE042403). Eligible participants will be office workers from the UCAM University with nonspecific spinal pain. Participants will be randomized into two groups. The experimental group will receive exercise therapy plus manual therapy, while the control group will receive exercise therapy plus sham manual therapy. Both groups will complete two 15-minute sessions of exercise therapy per week for 8 weeks. In addition, the experimental group will receive two 15-minute sessions of manual therapy per week, while the control group will receive sham manual therapy during the same period.
Outcomes: The primary outcomes will be self-perceived productivity, disability, patient global impression of change, and pain intensity. Secondary outcomes will include depression, anxiety, and muscle tone. Assessments will be conducted at baseline, post-intervention, and at 3- and 6-month follow-ups. Any possible adverse events will be registered during the 8-weeks of interventions.
Sample Size Estimation: Sample size was calculated using G*Power 3.1. To detect differences between groups over time, a small effect size (f = 0.17) was assumed, with 80% power and a 5% alpha level, indicating a minimum of 50 participants. Allowing for a 20% dropout rate, the target sample size was set at 60 participants (30 per group).
Statistical Analysis: A repeated-measures ANOVA (time × group) will be used. Mauchly's test will assess sphericity; if violated, the Greenhouse-Geisser correction will be applied. Post-hoc pairwise comparisons will be adjusted using Bonferroni correction. Effect sizes will be reported as partial eta-squared, and Cohen's d will be used for post-hoc comparisons. A chi-square test will assess the effectiveness of blinding by evaluating participants' perceptions of the intervention.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
This study's planned enrollment of 60 is close to the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →Catholic University of Murcia is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Compared within Low Back Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Back Pain. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 15-minute exercise therapy sessions twice per week at the workplace, including a 2-minute warm-up, 11-minute main phase, and 2-minute cool-down. The warm-up includes joint mobilization and low-load exercises. The main phase comprises six exercises in supersets, three sets of 10-12 reps with 30-second rests, divided into two blocks and targeting neck, back, and limbs, using body weight and elastic bands, with intensity rated 6-7/10 on the Borg Scale. The cool-down includes breathing and stretching exercises. Participants will also receive 15-minute manual therapy sessions twice per week, including the following myofascial techniques: nuchal ligament technique, transverse and longitudinal sliding of the paravertebral muscles on both sides of the back, and sustained pressure techniques applied to the trapezius and thoracolumbar fascia.
Behavioral: Exercise therapy · Procedure: Manual Therapy
Participants will receive the same exercise therapy protocol as the experimental group. In addition, they will receive 15-minute sham manual therapy sessions twice per week, delivered at the workplace. The sham intervention will mimic the duration, positioning, and therapist contact of the manual therapy procedures but will be applied without therapeutic intent or specific techniques to avoid producing physiological effects.
Behavioral: Exercise therapy · Procedure: Sham Manual Therapy
Exercises will target the neck, upper and lower back, and upper and lower limbs, and will include military press, lateral raises, front raises, trapezius raises, rear deltoid exercise, low- and high-row exercises, good mornings with extended arms, deadlifts, squats, lunges, biceps curls, chest press, and calf raises. The protocol will be performed twice a week for 8 weeks.
Manual therapy maneuvers twice per week for 8 weeks
Simulated manual therapy maneuvers twice per week for 8 weeks
Work productivity and pain-related activity impairment (WPAI: Pain)
WPAI: Pain is a self-reported instrument which assess impact of pain on work productivity and daily activities, including absenteeism, work-impairment, presenteeism, and activity-impairment
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Pain intensity (Numeric Rating Scale)
The Numeric Rating Scale (NRS) measures pain intensity on a scale from 0 (no pain) to 10 (worst possible pain), allowing self-reported assessment of pain intensity over the past week.
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Patient Global Impression of Change (PGIC)
The Patient Global Impression of Change (PGIC) assesses a patient's overall perception of improvement or change in their condition since the start of treatment, using a standardized 7-point scale from 'very much improved' to 'very much worse.'
Time frame: At 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Neck Disability Index (NDI)
Neck Disability Index (NDI) measures self-reported neck pain-related disability, including impact on daily activities, work, and function; higher scores indicate greater disability. Administered only to participants reporting neck pain
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Oswestry Disability Index (ODI)
The Oswestry Disability Index (ODI) measures self-reported disability related to low back pain, evaluating the impact on daily activities, work, and functional limitations, with higher scores indicating greater disability. Administered only to participants reporting low back pain
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Adverse events
Adverse events will be defined as any undesirable or harmful outcomes occurring during or after the intervention. At each exercise or manual therapy session, participants will be asked whether they have experienced any exacerbation of symptoms, including but not limited to pain, unusual fatigue, edema, tendinopathy, excessive delayed-onset muscle soreness (≥7/10), bursitis, or any other symptoms that limit or interfere with daily activities.
Time frame: During the 8 weeks of interventions.
Anxiety (GAD-7)
The GAD-7 questionnaire assesses the severity of generalized anxiety symptoms over the past two weeks, with higher scores indicating greater anxiety levels
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Severity of depressive symptoms (PHQ-9)
The PHQ-9 questionnaire assesses the severity of depressive symptoms over the past two weeks, with higher scores indicating greater depression levels
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Muscle Properties of Upper Trapezius (Myoton)
Myoton device measures mechanical properties of skeletal muscle. Upper trapezius tone will be measured at the midpoint between the C7 spinous process and the posterior acromion border on both sides. The three firing mode will be used.
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Muscle Properties of Lumbar zone (Myoton)
Myoton device measures mechanical properties of lumbar muscles. Tone will be measured 2.5 cm lateral to the L4-L5 space using the three-firing mode on both sides.
Time frame: At baseline, 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Adequate participant blinding
The success of participant blinding will be evaluated by asking participants whether they believe they received the experimental intervention and how confident they are in their response (0-10 numerical rating scale).
Time frame: At 8 weeks (end of treatment), 3 months, and 6 months post-treatment
Started Sep 2025 (actual). Primary completion is estimated for Jun 2027, 21 months after the start.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 21 months is above that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Catholic University of Murcia